Overview

Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy

Status:
Completed

Trial end date:
2012-07-01

Target enrollment:

Participant gender:

Summary

Phase III clinical trial to study quality of life in prostate cancer patients by randomizing anti-androgen versus total androgen blockage prior to curative intended radiation therapy.

Phase:

Phase 3

Details

Lead Sponsor:

Karolinska University Hospital

Treatments:

Androgen Antagonists
Androgens
Bicalutamide